Last reviewed · How we verify

NCT07378800

Fostering Positive Care Interactions in Assisted Living

Not yet recruiting NA Last updated 2 February 2026
What this trial tests

NA trial testing FPCI-AL in Dementia in 100 participants. Not yet recruiting.

Timeline
31 March 2026
Primary endpoint
31 March 2028
31 August 2028

Quick facts

Lead sponsorUniversity of Maryland, Baltimore
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposesupportive care
Enrollment100
Start date31 March 2026
Primary completion31 March 2028
Estimated completion31 August 2028

Drugs / interventions tested

Conditions studied

Sponsor

University of Maryland, Baltimore

Who can join

55 and older, any sex, with Dementia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to improve the quality of staff-resident care interactions particularly among residents living with Alzheimer's disease or related dementias (ADRD ) by testing the Fostering Positive Care Interactions in Assisted Living (FPCI-AL) intervention. This study will be a critical first step in determining the sample size needed to test the efficacy of a practical approach to improving the quality of care interactions for assisted living residents living with ADRD, ultimately enhancing behavioral outcomes such as decreasing behavioral symptoms of distress, reducing resistiveness to care, and optimizing engagement in care tasks.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Dementia

Currently open trials in the same condition.

Other University of Maryland, Baltimore trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07378800.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing